Form 8-K - Current report:
SEC Accession No. 0001437749-21-021916
Filing Date
2021-09-10
Accepted
2021-09-10 16:05:39
Documents
13
Period of Report
2021-09-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20210909_8k.htm   iXBRL 8-K 45509
  Complete submission text file 0001437749-21-021916.txt   181902

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arav-20210910.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20210910_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20210910_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20210910_pre.xml EX-101.PRE 12022
6 EXTRACTED XBRL INSTANCE DOCUMENT arav20210909_8k_htm.xml XML 2653
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 211247130
SIC: 2834 Pharmaceutical Preparations